Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-10-001267
Filing Date
2010-05-12
Accepted
2010-05-12 15:35:44
Documents
1
Period of Report
2010-05-10

Document Format Files

Seq Description Document Type Size
1 a1008281_ex.html 4  
1 a1008281_ex.xml 4 2888
  Complete submission text file 0001178913-10-001267.txt   4864
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-4-850-1080
PLURISTEM THERAPEUTICS INC (Issuer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 63 RABUTZKY STREET RAANANA L3 43220
Business Address
Aberman Zami (Reporting) CIK: 0001344740 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31392 | Film No.: 10824312